Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).

Míreanna Comhchosúla

• Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.
  le: Cusack, N. J., et al.
  Foilsithe: (1981)
• Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
  le: Cusack, N. J., et al.
  Foilsithe: (1981)
• Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
  le: Cusack, N. J., et al.
  Foilsithe: (1982)
• Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
  le: Cusack, N. J., et al.
  Foilsithe: (1982)
• The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E(1)
  le: Boullin, D. J., et al.
  Foilsithe: (1972)